Literature DB >> 33030980

Continuum of Care for Hodgkin Lymphoma: Impact of Modern Therapy on Postacute Morbidity and Mortality.

Andrew M Evens1, Susan K Parsons2.   

Abstract

Entities:  

Year:  2020        PMID： 33030980      PMCID： PMC7723688          DOI： 10.1200/JCO.20.02668

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  34 in total

1.  Measuring the societal burden of cancer: the cost of lost productivity due to premature cancer-related mortality in Europe.

Authors:  Paul Hanly; Isabelle Soerjomataram; Linda Sharp
Journal:  Int J Cancer       Date:  2014-09-04       Impact factor: 7.396

2.  A population-based study of cardiac morbidity among Hodgkin lymphoma patients with preexisting heart disease.

Authors:  Sten Myrehaug; Melania Pintilie; Lingsong Yun; Michael Crump; Richard W Tsang; Ralph M Meyer; Jonathan Sussman; Eric Yu; David C Hodgson
Journal:  Blood       Date:  2010-07-01       Impact factor: 22.113

Review 3.  Therapeutic recommendations for early stage Hodgkin lymphomas.

Authors:  Julien Depaus; Anne Delcourt; Marc André
Journal:  Br J Haematol       Date:  2018-11-28       Impact factor: 6.998

4.  The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496.

Authors:  Andrew M Evens; Fangxin Hong; Leo I Gordon; Richard I Fisher; Nancy L Bartlett; Joseph M Connors; Randy D Gascoyne; Henry Wagner; Mary Gospodarowicz; Bruce D Cheson; Patrick J Stiff; Ranjana Advani; Thomas P Miller; Richard T Hoppe; Brad S Kahl; Sandra J Horning
Journal:  Br J Haematol       Date:  2013-01-29       Impact factor: 6.998

5.  Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials.

Authors:  Boris Böll; Helen Goergen; Karolin Behringer; Paul J Bröckelmann; Felicitas Hitz; Andrea Kerkhoff; Richard Greil; Bastian von Tresckow; Dennis A Eichenauer; Carolin Bürkle; Sven Borchmann; Michael Fuchs; Volker Diehl; Andreas Engert; Peter Borchmann
Journal:  Blood       Date:  2016-02-01       Impact factor: 22.113

6.  Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma.

Authors:  Deborah M Stephens; Hongli Li; Heiko Schöder; David J Straus; Craig H Moskowitz; Michael LeBlanc; Lisa M Rimsza; Nancy L Bartlett; Andrew M Evens; Ann S LaCasce; Paul M Barr; Michael V Knopp; Eric D Hsi; John P Leonard; Brad S Kahl; Sonali M Smith; Jonathan W Friedberg
Journal:  Blood       Date:  2019-10-10       Impact factor: 25.476

Review 7.  Health-related quality of life in Hodgkin lymphoma: a systematic review.

Authors:  Nadine Linendoll; Tully Saunders; Rebecca Burns; Jonathan D Nyce; Kristen B Wendell; Andrew M Evens; Susan K Parsons
Journal:  Health Qual Life Outcomes       Date:  2016-07-29       Impact factor: 3.186

8.  Early-stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long-term patient outcomes.

Authors:  Susan K Parsons; Michael J Kelly; Joshua T Cohen; Sharon M Castellino; Tara O Henderson; Kara M Kelly; Frank G Keller; Tobi J Henzer; Anita J Kumar; Peter Johnson; Ralph M Meyer; John Radford; John Raemaekers; David C Hodgson; Andrew M Evens
Journal:  Br J Haematol       Date:  2018-04-29       Impact factor: 6.998

9.  Patient and physician preferences for first-line treatment of classical Hodgkin lymphoma in Germany, France and the United Kingdom.

Authors:  Paul J Bröckelmann; Suzanne McMullen; J Ben Wilson; Kerstin Mueller; Sarah Goring; Aspasia Stamatoullas; Erin Zagadailov; Ashish Gautam; Dirk Huebner; Mehul Dalal; Tim Illidge
Journal:  Br J Haematol       Date:  2018-09-21       Impact factor: 6.998

10.  Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.

Authors:  Peter Johnson; Massimo Federico; Amy Kirkwood; Alexander Fosså; Leanne Berkahn; Angelo Carella; Francesco d'Amore; Gunilla Enblad; Antonella Franceschetto; Michael Fulham; Stefano Luminari; Michael O'Doherty; Pip Patrick; Thomas Roberts; Gamal Sidra; Lindsey Stevens; Paul Smith; Judith Trotman; Zaid Viney; John Radford; Sally Barrington
Journal:  N Engl J Med       Date:  2016-06-23       Impact factor: 91.245
View more
  1 in total

1.  Informing radiotherapy decisions in stage I/IIa Hodgkin lymphoma: modeling life expectancy using radiation dosimetry.

Authors:  David A Jones; Paolo Candio; Rebecca Shakir; Georgios Ntentas; Johanna Ramroth; Alastair M Gray; David J Cutter
Journal:  Blood Adv       Date:  2022-02-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.